By Ria Kakkad (Drug Target Review)2023-01-27T15:53:54
Scientists from Rice University are using fluorescence lifetime to shed new light on a peptide associated with Alzheimer’s disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud